Gene Expression Global Market Report 2024

The gene expression market size has grown rapidly in recent years. It will grow from $10.54 billion in 2023 to $11.68 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be attributed to factors such as an increasing focus on precision medicine, a rise in cancer research and biomarker discovery, the application of gene expression in disease diagnosis and prognosis, integration with systems biology approaches, and the evolving needs in drug discovery and development.

The gene expression market size is expected to see rapid growth in the next few years. It will grow to $18.07 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The anticipated growth in the forecast period can be attributed to the emergence of spatial transcriptomics, an increase in epigenomic studies, global health events and pandemic preparedness efforts, a heightened focus on non-coding RNA exploration, and increased utilization in immunotherapy research. Major trends expected in the forecast period include the widespread adoption of single-cell RNA sequencing, advancements in next-generation sequencing technologies, the integration of multi-omics data, progress in gene editing technologies, the development of liquid biopsy techniques, and the application of spatial omics in drug discovery.

The anticipated increase in emphasis on precision medicine is set to drive the growth of the gene expression market in the future. Precision medicine utilizes information about an individual's genes or proteins to diagnose, prevent, or treat diseases. Gene expression plays a crucial role in precision medicine by identifying abnormalities in normal function and physiological regulation through the measurement and comparison of genes and transcripts in tissues with different medical conditions, facilitating patient-centric treatment. For example, in 2021, precision medicines accounted for over 25% of FDA approvals in the last seven years, with an additional 35% of medicines approved in 2021 being precision medicines, as reported by the Personalized Medicine Coalition. Hence, the heightened focus on precision medicine is a driving force behind the gene expression market.

The increase in chronic diseases is expected to contribute to the growth of the gene expression market in the future. Chronic diseases are prolonged medical conditions persisting over three months or more. Gene expression analysis is employed in chronic diseases to comprehend the molecular mechanisms underlying these conditions, identify potential biomarkers, and develop targeted therapies. For instance, a report by the National Library of Medicine in January 2023 projected a 99.5% increase in individuals aged 50 years and older with one or more chronic illnesses by 2050 in the United States, reaching 142.66 million, up from 71.522 million in 2020. Therefore, the rise in chronic diseases is poised to drive the growth of the gene expression market.

Technological advancement stands out as a notable trend in the gene expression market, with major companies progressing towards RNA gene expression technology. For instance, in September 2022, Enzo Biochem, Inc., introduced AMPIVIEW, a new platform leveraging RNA gene expression technology for superior sensitivity in detecting and visualizing biomarkers in cells and tissue samples, specifically targeting HPV and SARS-CoV-2.

Major companies in the gene expression market are concentrating on innovative product development, such as gene detection assays, to gain a competitive edge and enhance revenue. Gene detection assays involve methods for identifying and quantifying the presence of genetic molecules, offering insights into the activity and abundance of specific genes. In January 2023, Bio-Techne Corporation expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This assay allows simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, providing single-cell and subcellular resolution.

In October 2021, Bionano Genomics Inc. acquired BioDiscovery for a deal value of $100 million. This strategic acquisition enables Bionano to offer additional structural variations and methylation analysis, providing end-users with a comprehensive genomic view of the sample. BioDiscovery is a company based in the US that specializes in genomic software for clinical and research applications using NGS and/or microarrays.

Major companies operating in the gene expression market report are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, Quest Diagnostics Inc., Interpace Biosciences Inc., OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, AutoGenomics Inc., Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, QIAGEN Inc., Quest Diagnostics Incorporated, Roche Holding AG, Sengenics Corporation Pte Ltd., GenoSensor Corporation, GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation.

North America was the largest region in the gene expression market in 2023. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gene expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products associated with gene expression include kits and reagents, DNA chips or microarrays, and others. Kits and reagents are testing kits employed to detect specific substances either in a laboratory or in the field. The major processes involved in gene expression include sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation. Techniques related to gene expression encompass RNA expression, promoter analysis, protein expression, and posttranslational modification analysis. These methods find applications in various fields such as drug discovery and development, clinical diagnostics, biotechnology, microbiology, and other related areas.

The gene expression market research report is one of a series of new reports that provides gene expression market statistics, including gene expression industry global market size, regional shares, competitors with a gene expression market share, detailed gene expression market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. This gene expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.